{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:12:30Z","timestamp":1780492350218,"version":"3.54.1"},"reference-count":55,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Antisense therapy is widely used as an alternative therapeutic option for various diseases. RNA interference might be effective in infections, through the degradation of messenger RNA and, therefore, translation process. Hence, proteins essential for microorganisms and viruses\u2019 proliferation and metabolism are inhibited, leading to their elimination. The present study aimed to evaluate the use of oligonucleotide in patients infected by Epstein\u2013Barr (EBV) or Herpes Simplex Viruses 1\/2 or with Lyme Disease caused by Borrelia burgdorferi. Blood samples were collected from 115 patients and the different species were characterized using molecular biology techniques. Then, SOT molecules (Supportive Oligonucleotide Therapy), which are specific small interfering RNA (siRNA), were designed, produced, and evaluated, for each specific strain. Oligonucleotides were administered intravenously to patients and then a quantitative Polymerase Chain Reaction was used to evaluate the effectiveness of SOT. This study revealed that for Lyme Disease, one or two SOT administrations can lead to a statistically significant decrease in DNA copies, while for viruses, two or three administrations are required to achieve a statistically significant reduction in the genetic material. These preliminary results indicate that antisense SOT therapy can be considered a potential treatment for viral as well as Lyme diseases.<\/jats:p>","DOI":"10.3390\/idr14060084","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T03:28:10Z","timestamp":1667532490000},"page":"824-836","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Supportive Oligonucleotide Therapy (SOT) as a Potential Treatment for Viral Infections and Lyme Disease: Preliminary Results"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-1114","authenticated-orcid":false,"given":"Panagiotis","family":"Apostolou","sequence":"first","affiliation":[{"name":"Research Genetic Cancer Centre S.A., Industrial Area of Florina, 53100 Florina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggelos","family":"Iliopoulos","sequence":"additional","affiliation":[{"name":"Research Genetic Cancer Centre S.A., Industrial Area of Florina, 53100 Florina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-7139","authenticated-orcid":false,"given":"Georgios","family":"Beis","sequence":"additional","affiliation":[{"name":"Research Genetic Cancer Centre S.A., Industrial Area of Florina, 53100 Florina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Papasotiriou","sequence":"additional","affiliation":[{"name":"Research & Development, Research Genetic Cancer Centre International GmbH, 6300 Zug, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tarn, W.Y., Cheng, Y., Ko, S.H., and Huang, L.M. (2021). Antisense oligonucleotide-based therapy of viral infections. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13122015"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA Interference: Biology, Mechanism, and Applications","volume":"67","author":"Agrawal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.21873\/invivo.12779","article-title":"Supportive Oligonucleotide Therapy (SOT) as an Alternative Treatment Option in Cancer: A Preliminary Study","volume":"36","author":"Papasotiriou","year":"2022","journal-title":"In Vivo"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10848","DOI":"10.1128\/JVI.78.20.10848-10855.2004","article-title":"Lentivirus-Mediated RNA Interference of DC-SIGN Expression Inhibits Human Immunodeficiency Virus Transmission from Dendritic Cells to T Cells","volume":"78","author":"Arrighi","year":"2004","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymthe.2005.10.013","article-title":"Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs","volume":"13","author":"Carmona","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4939-1538-5_14","article-title":"Therapy of respiratory viral infections with intranasal siRNAs","volume":"1218","author":"Barik","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00253-017-8671-0","article-title":"Advances in therapeutic bacterial antisense biotechnology","volume":"102","author":"Hegarty","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Karim, S., Kenny, B., Troiano, E., and Mather, T.N. (2008). RNAi-mediated gene silencing in tick synganglia: A proof of concept study. BMC Biotechnol., 8.","DOI":"10.1186\/1472-6750-8-30"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V92.5.1721","article-title":"Antisense to the Epstein-Barr Virus (EBV)-Encoded Latent Membrane Protein 1 (LMP-1) Suppresses LMP-1 and Bcl-2 Expression and Promotes Apoptosis in EBV-Immortalized B Cells","volume":"92","author":"Kenney","year":"1998","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02255642","article-title":"Inhibition of the synthesis of proteins needed for Epstein-Barr virus replication by antisense RNA against the zta gene","volume":"4","author":"Liu","year":"1997","journal-title":"J. Biomed. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood.V84.2.582.582","article-title":"Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells","volume":"84","author":"Roth","year":"1994","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1025346131903","article-title":"RNA Interference: Applicability in Tick Research","volume":"28","author":"Aljamali","year":"2002","journal-title":"Exp. Appl. Acarol."},{"key":"ref_13","unstructured":"Feng, C., Torimaru, K., Lim, M.Y.T., Chak, L.-L., Tsuji, K., Tanaka, T., Lida, J., and Okamura, K. (2021). RNA-dependent RNA polymerases in the black-legged tick produce Argonaute-dependent small RNAs and regulate genes. bioRxiv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1534735412458827","article-title":"Thymoquinone efficiently inhibits the survival of EBV-infected B cells and alters EBV gene expression","volume":"12","author":"Zihlif","year":"2013","journal-title":"Integr. Cancer Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3855\/jidc.6199","article-title":"hospital-based pilot study on Epstein-Barr virus in suspected infectious mononucleosis pediatric patients in India","volume":"9","author":"Janani","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Richardson, A.K., Currie, M.J., Robinson, B.A., Morrin, H., Phung, Y., Pearson, J.F., Anderson, T.P., Potter, J.D., and Walker, L.C. (2015). Cytomegalovirus and Epstein-Barr Virus in Breast Cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118989"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by a polymerase chain reaction in synovial fluid from patients with Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_18","unstructured":"Hancock, G.R., Stapleton, L.M., and Mueller, R.O. (2019). Analysis of variance: Repeated-measures designs. The Reviewer\u2019s Guide to Quantitative Methods in the Social Sciences, Routledge\/Taylor & Francis Group. [2nd ed.]."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1213\/ANE.0000000000003511","article-title":"Repeated measures designs and analysis of longitudinal data: If at first you do not succeed-try, try again","volume":"127","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/aca.ACA_94_19","article-title":"Application of student\u2019s t-test, analysis of variance, and covariance","volume":"22","author":"Mishra","year":"2019","journal-title":"Ann. Card. Anaesth."},{"key":"ref_21","unstructured":"Kassambara, A. (2019). Practical Statistics in R II. Comparing Groups: Numerical Variables, Datanovia."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Girden, E.R. (1992). ANOVA Repeated Measures, Newbury Park, Sage Publications, Inc.","DOI":"10.4135\/9781412983419"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An Analysis of Variance Test for Normality (Complete Samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01621459.1937.10503522","article-title":"The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance","volume":"32","author":"Friedman","year":"1937","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1214\/aoms\/1177731944","article-title":"A Comparison of Alternative Tests of Significance for the Problem of m Rankings","volume":"11","author":"Friedman","year":"1940","journal-title":"Ann. Math. Stat."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Marino, M.J. (2018). Chapter 3: Statistical Analysis in Preclinical Biomedical Research. Research in the Biomedical Sciences, Academic Press.","DOI":"10.1016\/B978-0-12-804725-5.00003-3"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2307\/1165229","article-title":"Multiple Testing and Statistical Power with Modified Bonferroni Procedures","volume":"22","author":"Olejnik","year":"1997","journal-title":"J. Educ. Behav. Stat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"ref_29","first-page":"19","article-title":"The need to report effect size estimates revisited. An overview of some recommended measures of effect size Language and cognition","volume":"1","author":"Tomczak","year":"2014","journal-title":"TRENDS Sport Sci."},{"key":"ref_30","unstructured":"R Core Team (2020). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: http:\/\/www.R-project.org\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"key":"ref_32","unstructured":"Kassambara, A., and ggpubr: \u2018ggplot2\u2032 Based Publication Ready Plots (2020, June 27). R Package Version 040. Available online: https:\/\/CRAN.R-project.org\/package=ggpubr."},{"key":"ref_33","unstructured":"Kassambara, A., and rstatix: Pipe-Friendly Framework for Basic Statistical Tests (2020, February 13). R Packag Version 0.4.0. Available online: https:\/\/cran.microsoft.com\/snapshot\/2020-04-20\/web\/packages\/rstatix\/index.html."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3758\/BF03192707","article-title":"Recommended effect size statistics for repeated measures designs","volume":"37","author":"Bakeman","year":"2005","journal-title":"Behav. Res. Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"283","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"38","author":"Rezk","year":"2007","journal-title":"Hum. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00430-018-0570-1","article-title":"Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis","volume":"208","author":"Yin","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.semcancer.2008.10.004","article-title":"Multiple roles of LMP1 in Epstein-Barr virus induced immune escape","volume":"18","author":"Middeldorp","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1038\/sj.onc.1205515","article-title":"Antisense to Epstein Barr virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes","volume":"21","author":"Masciarelli","year":"2002","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-005-0036-x","article-title":"Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt\u2019s lymphoma cells","volume":"132","author":"Hong","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.onc.1201183","article-title":"Inhibition of in vitro proliferation of Epstein Barr Virus infected B cells by an antisense oligodeoxynucleotide targeted against EBV latent membrane protein LMP1","volume":"15","author":"Mattia","year":"1997","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11910-013-0414-8","article-title":"Update on herpes virus infections of the nervous system","volume":"13","author":"Steiner","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/jvi.68.2.834-845.1994","article-title":"Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells","volume":"68","author":"Dingwell","year":"1994","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","article-title":"Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management","volume":"57","author":"Fatahzadeh","year":"2007","journal-title":"J. Am. Acad Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1021\/bi00045a001","article-title":"Inhibition of Herpes Simplex Virus Replication by Antisense Oligo-2\u2032-O-methylribonucleoside Methylphosphonates","volume":"34","author":"Kean","year":"1995","journal-title":"Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kalke, K., Lehtinen, J., Gnjatovic, J., Lund, L.M., Nyman, M.C., Paavilainen, H., Orpana, J., Lasanen, T., Frejborg, F., and Levanova, A.A. (2020). Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity. Viruses, 12.","DOI":"10.3390\/v12121434"},{"key":"ref_47","unstructured":"Skar, G.L., and Simonsen, K.A. (2022, May 06). Lyme Disease, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK431066\/."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.17843\/rpmesp.2018.352.3418","article-title":"Lyme disease in Peru. A clinical and epidemiological review","volume":"35","author":"Cervantes","year":"2018","journal-title":"Rev. Peru Med. Exp. Salud Publica"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13071-019-3548-y","article-title":"Is selenoprotein K required for Borrelia burgdorferi infection within the tick vector Ixodes scapularis?","volume":"12","author":"Kumar","year":"2019","journal-title":"Parasites Vectors"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1076\/ocii.7.3.189.4007","article-title":"Fomivirsen\u2014A phosphorothioate oligonucleotide for the treatment of CMV retinitis","volume":"7","author":"Meenken","year":"1999","journal-title":"Ocul. Immunol. Inflamm"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: The next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/ard.1995.5.241","article-title":"Phosphorothioate Oligodeoxynucleotides: Antisense or Anti-Protein?","volume":"5","author":"Krieg","year":"1995","journal-title":"Antisense Antisense Res. Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/156802607780487713","article-title":"2-Modified Oligonucleotides for Antisense Therapeutics","volume":"7","author":"Prakash","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/mtna.2012.30","article-title":"Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates with Improved Cardiac Exon Skipping Activity for DMD Treatment","volume":"1","author":"Betts","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/14\/6\/84\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:10:20Z","timestamp":1760145020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/14\/6\/84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["idr14060084"],"URL":"https:\/\/doi.org\/10.3390\/idr14060084","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}